<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432117/" ref="ordinalpos=4955&amp;ncbi_uid=4217912&amp;link_uid=PMC3432117" image-link="/pmc/articles/PMC3432117/figure/pone-0044570-g002/" class="imagepopup">Figure 2. BMS309403 stimulates glucose uptake in C2C12 myotubes and AMPK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in a dose dependent manner..  From: BMS309403 Stimulates Glucose Uptake in Myotubes through Activation of AMP-Activated Protein Kinase. </a></div><br /><div class="p4l_captionBody">C2C12 myotubes were starved for 2 hours in serum free high glucose DMEM containing 0.2%BSA followed by incubation for 2 h with the indicated concentrations of BMS309403. (A) 2-deoxy-D[1-3H]-glucose was added for 15 min at 37Â°C, followed by glucose uptake measurement. (B) Western blotting analysis of AMPK and Akt signaling molecules.</div></div>